Article Details

Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic ...

Retrieved on: 2022-10-11 18:17:37

Tags for this article:

Click the tags to see associated articles and topics

Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic .... View article details on hiswai:

Excerpt

11, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced data demonstrating the ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up